—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Almirall S.A. (ALM.MC) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 55 out of 100 (momentum 42 · quality 46 · valuation 66), as of 2026-11-04.
  • Signal: Recovery attempt under the 200-day — Trades +5.3% vs the 50-day and -4.2% vs the 200-day average, 21% below the 52-week high and +11.1% off the 52-week low. Computed from daily closes. (as of 2026-11-03)
  • Trend: Almirall S.A. trades 5.3% above its 50-day and 4.2% below its 200-day moving average. (as of 2026-11-03)

Almirall develops medicines for skin conditions such as psoriasis, atopic dermatitis, acne and actinic keratosis, alongside products in several other therapeutic areas. It runs a pipeline of experimental compounds at different trial stages, often working with outside research partners on early-stage science.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ALM.MC overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +5.3% vs the 50-day and -4.2% vs the 200-day average, 21% below the 52-week high and +11.1% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ALM.MC chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on ALM.MC?

Recovery attempt under the 200-day — Trades +5.3% vs the 50-day and -4.2% vs the 200-day average, 21% below the 52-week high and +11.1% off the 52-week low. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ALM.MC above its 50-day and 200-day moving averages?

As of 2026-11-03, Almirall S.A. trades +5.3% above its 50-day and -4.2% below its 200-day average, with the 20-day +5.9% away.

How far is ALM.MC from its 52-week high?

21% below the 52-week high and 11.1% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.